First of all, my outstanding Secretary of Education, Arne Duncan, is in the house. (Applause.) Superintendant of Columbus City Schools, Dr. Gene T.
At some unknown time in the past, genetic mutations occurred that didn't prevent a gene from doing its job but did cripple it slightly.
WSJ: A Gene Gives a Hint Of How Long a Person Might Hope to Live
Attacking one bad gene won't halt these tumors' growth for long.
Paul Ridker, the Harvard cardiologist who headed up the study, notes that all of these patients should still be taking cholesterol drugs, and that this gene alone probably won't be turned into a diagnostic test.
The laborious process entails isolating a patient's T cells and inserting a new gene.
And I'm going to acknowledge also Gene Sperling, who doesn't always get the credit he deserves for doing outstanding work.
WHITEHOUSE: President Obama Speaks on Landmark Housing Settlement with Banks | The White House
Now come two unconventional thinkers, a physicist in New Mexico and a biologist in Massachusetts, with an arresting question: If such diseases are indeed genetic, and if they impair reproductive success, why haven't the traits disappeared from the gene pool by now?
Some 600, 000 Americans have a less severe version caused by one defective copy. (There would be more of the double-gene victims if they didn't die young.) To get its drug approved Isis will need to study 45 patients with the severe two-gene form and a few hundred with the single-gene disease.
They also haven't been able to identify a typical gene disorder that may be the source.
It won't be long until the knowledge of gene-disease associations improves.
The gene produces a molecular sensor on the T cell that is designed to latch on to a telltale protein on the surface of that specific type of cancer.
The White House's top economic adviser, Gene Sperling, said the pain isn't that bad right now.
If genes are making several proteins, knowing that a gene is involved in a disease isn't enough.
According to her husband, Debbie Martin had the same defective BRCA1 gene that Jolie does, but didn't know it until after her 2004 cancer diagnosis.
When he finished in 1992, he didn't have enough funding left to put the gene in bacteria--a necessary test if he was to be sure he had the right DNA sequence.
Compared to Gene Wisoff, Needle says, Buckley wasn't all that demanding.
That's because very soon 40% of patients who previously might have gotten Erbitux will not get it any more because the gene test reveals in advance the drug won't work.
Besides Forbes, Gene Marks writes weekly for The New York Times and T he Huffington Post.
But it can't compete with IBM's work in progress, Blue Gene, unless it's ten times that fast.
The FDA, a full four years after the first gene-targeted cancer drug hit the market, hasn't issued guidelines for what drugmakers should do to target new treatments at the smaller circle of patients who are most likely to benefit.
It wasn't until Genentech showed that it worked in patients whose tumors had a gene called HER2 that the drug made it to market.
Two stand up comedians, united by a common interest in all things scientific, we know that the difference between the sexes doesn't boil down to shopping and map reading, but to the SrY gene.
Gene DeWitt, president of media buyer and consultancy DeWitt Media Strategies, isn't so sure.
If a gene makes an erroneous "developmental decision, " cells grow where they shouldn't.
Researchers weren't focusing on leukemia, but one compound they produced could disable the defective protein made by the CML gene.
Not everyone has the leadership gene, he argues, and large companies need to find a way of making those who don't get to the top feel more valued.
应用推荐